1. Home
  2. ABAT vs DBVT Comparison

ABAT vs DBVT Comparison

Compare ABAT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$4.01

Market Cap

522.9M

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$18.29

Market Cap

508.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
DBVT
Founded
2011
2002
Country
United States
France
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.9M
508.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABAT
DBVT
Price
$4.01
$18.29
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$24.46
AVG Volume (30 Days)
6.0M
452.4K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,025,853.00
$5,502,000.00
Revenue This Year
$145.40
$1,768.71
Revenue Next Year
N/A
$1,028.88
P/E Ratio
N/A
N/A
Revenue Growth
821.40
N/A
52 Week Low
$0.83
$2.74
52 Week High
$11.49
$21.50

Technical Indicators

Market Signals
Indicator
ABAT
DBVT
Relative Strength Index (RSI) 48.76 69.42
Support Level $3.86 $17.86
Resistance Level $4.32 $21.50
Average True Range (ATR) 0.34 1.22
MACD 0.09 0.63
Stochastic Oscillator 59.17 66.53

Price Performance

Historical Comparison
ABAT
DBVT

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: